|
Disparities in biomarker testing in ovarian cancer: a real-world analysis
|
August 25, 2022
|
PC3I Authors Anna Jo Smith; Emily Ko |
American Journal of Obstetrics and Gynecology
|
|
Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomies
|
September 2, 2022
|
PC3I Authors Emily Ko |
Gynecologic Oncology Reports
|
|
Prior authorization in gynecologic oncology: An analysis of clinical impact
|
October 16, 2022
|
PC3I Authors Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko |
Gynecologic Oncology
|
|
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma
|
December 12, 2022
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Insurance and racial disparities in prior authorization in gynecologic oncology
|
March 21, 2023
|
PC3I Authors Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko |
Gynecologic Oncology Reports
|
|
Disparities in clinical trial participation in ovarian cancer: A real-world analysis
|
June 10, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study
|
September 21, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology Reports
|
|
Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients
|
July 3, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
|
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma
|
August 23, 2023
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Current diagnostic guidelines and perpetuation of inequities in ovarian cancer: A National Cancer Database study.
|
May 29, 2024
|
PC3I Authors Anna Jo Smith; Emily Gleason; Anne Marie McCarthy |
Journal of Clinical Oncology
|
|
Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes
|
September 4, 2023
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Transportation assistance in gynecologic oncology: A pilot study.
|
October 26, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko; Justin Bekelman |
JCO Oncology Practice
|
|
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes
|
September 25, 2023
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Addressing transportation barriers in oncology: existing programs and new solutions
|
April 29, 2024
|
PC3I Authors Emily Ko; Meredith Doherty; Anna Jo Smith |
Supportive Care in Cancer
|
|
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery
|
October 25, 2023
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Ovarian Cancer Isn’t Just a White Woman’s Disease
|
April 4, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
|
November 29, 2023
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?
|
March 16, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma
|
December 13, 2023
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database
|
May 6, 2021
|
PC3I Authors Emily Ko |
Surgical Oncology
|
